MULTIPLE MYELOMA

Latest News

FDA's Oncologic Drugs Advisory Committee Casts Interesting Votes
FDA's Oncologic Drugs Advisory Committee Casts Interesting Votes

July 14th 2025

The FDA evaluates glofitamab and daratumumab for lymphoma and myeloma treatments, highlighting trial demographics and clinical outcomes in recent ODAC meeting.

Exploring MRD Testing and Data in Myeloma to Guide Treatment Decisions
Exploring MRD Testing and Data in Myeloma to Guide Treatment Decisions

July 10th 2025

MIDAS Trial: ASCT Offers No MRD Benefit Over Isa-KRd in Myeloma
MIDAS Trial: ASCT Offers No MRD Benefit Over Isa-KRd in Myeloma

July 10th 2025

Newer Approaches Show Potential to Reduce Need for Transplant in NDMM
Newer Approaches Show Potential to Reduce Need for Transplant in NDMM

July 9th 2025

More News